Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma.
about
Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@en
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@nl
type
label
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@en
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@nl
prefLabel
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@en
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Efficacy of topotecan in pretr ...... nary neuroendocrine carcinoma.
@en
P2093
Dirk Jäger
Eva Caroline Winkler
Frank Bergmann
Leonidas Apostolidis
P2860
P304
P356
10.1002/CAM4.807
P407
P577
2016-07-25T00:00:00Z